A16Z Exec Steven Sinofsky Faces Epstein Scrutiny Now
A new wave of questions surrounds a16z exec steven sinofsky as reports tie him to Epstein during his Microsoft exit. ...
Why Does My Budget Fail Every Month
Pinpoint root causes, such as leakage or overspending, then implement targeted adjustments to regain monthly balance.
24,041 articlesExxon, Chevron, Other Producers Rally as Oil Prices Soar
Exxon Mobil, Chevron and other producers climb to all-time stock valuations as geopolitical risk pushes energy prices...
What Happens When You Ignore Slippage? $50M DeFi Swap Fallout
A single, massive swap stirred chaos in the DeFi space when extreme slippage warnings were ignored. The trader receiv...
China’s Alibaba Predicts Price: Crypto Bets for 2026
Alibaba’s AI projects a bullish path for XRP, Bitcoin and Ethereum by late 2026, even as regulators refine crypto rul...
Super Micro CEO: We’re at the Center of AI Buildout
Super Micro Computer delivered a blowout Q2 as AI infrastructure demand drives orders for its Data Center Building Bl...
Mastercard Visa Stocks Safely: A Forever-Hold Bet Today
In a volatile market, Mastercard and Visa are reinforcing their status as durable, long-term holdings. A growing paym...
What’s Behind Million Investment in Flooring Stock Decline
A sizable $12 million stake in a floor-and-decor retailer arrives as the stock trades off. This article breaks down t...
ACMR KLIC: The Battle in Semiconductor Stocks Heats Up
ACM Research and Kulicke & Soffa diverge in a pivotal semiconductor tool quarter, with ACMR posting record sales but ...
Betting Against Semiconductors: A Contrarian Bet Gone Sour
A bold contrarian wager on semiconductors has underperformed as AI demand sustains a rally. Leveraged, daily-reset fu...
Inside Mind Active Trader: Leveraged ETFs in Major Moves
Retail traders drove a large share of leveraged ETF activity in late 2025 as markets swung. This piece examines the p...
Microsoft’s Worst Start Since 2008: Buy the Dip?
Microsoft kicks off 2026 with a rough start as earnings beat clashes with a surge in capital expenditures. Traders de...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status